We’re the UK’s leading ovarian cancer research charity, working on early detection, prevention and treatments so that no woman dies of ovarian cancer.
Who we are and what we do?
Ovarian Cancer Action is a community of changemakers with one purpose: to give ovarian cancer the focus it needs to increase 10-year survival rates. And we know research is the solution.
We live and breathe this lifesaving, world-leading research. We fund more ovarian cancer research than any other UK gynaecological cancer charity. It’s how we’ve driven some of the biggest breakthroughs of the last 19 years.
We’re also the only charity at the heart of the global ovarian cancer research community and have been for four decades.
By connecting the world’s leading scientists together, we’re creating a powerful hub of experience, expertise and insight. So, we confidently fund research that takes us a step closer to our goal: that by 2032 half of women will live more than 10 years after diagnosis.
Progress has been made over last 30 years, but it’s not enough. Ovarian cancer is an incredibly complex disease with shockingly low survival rates. The Covid pandemic and Brexit has made the situation worse for patients and has also affected the UK research community over the last few years. We must accelerate progress, so we see the same fast and consistent improvements in ovarian cancer as we’ve seen in prostate and breast cancer.
We have a huge challenge on our hands, so we need people up for this challenge. People who bring determination, passion, commitment, and creativity that can turn the tide on ovarian cancer. We are mid-way through our five-year strategy, a renewed focus on research and ambitious plans to drive forward progress at a faster pace. Can you help us achieve our goals?
Ovarian Cancer Action’s Impact Strategy.
Late diagnosis, limited treatment options, 70% chance of recurrence are some of the unacceptable reasons women are dying from ovarian cancer and why we’re committed to putting a stop to it.
From our research centre we’ve sparked life-changing discoveries across the globe. But there’s much more to do. Our goal is to make sure by 2032 half of women live more than 10 years after diagnosis.
So, we’re supercharging progress.
We’re innovating treatment.
New drugs. Personalised treatment. We’re developing and trialing new approaches to cure and manage ovarian cancer. One of our teams is seeing if a successful breast cancer drug can be used to treat ovarian cancer.
We’re enabling early detection that saves lives.
When cancer is found early women have a much better chance of surviving for longer. We’re making discoveries to make an ovarian cancer screening test a reality.
We’re making prevention a possibility.
We’re discovering and sharing information on risk. So, every woman knows her options and can take control of her future.
We’re making care equal.
No woman should lose her life to ovarian cancer because of her age, her race or where she lives. We’re driving change to make sure every woman has the best treatment possible. Our IMPROVE programme is levelling up the quality of care across UK.
We’re sharing the warning signs.
In 2009 we led the campaign for the Department of Health to recognise the four main symptoms of ovarian cancer – ending the myth that ovarian cancer is a silent killer.
Board of directors.
Please find profiles of the Board of Directors here
Watch this video to learn more about what we do and the impact we have…….